Zarei, M., Du, H., Nassar, A. H., Yan, R. E., Giannikou, K., Johnson, S. H., . . . Kwiatkowski, D. J. (2019). Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion. J Exp Med.
Styl cytowania ChicagoZarei, Mahsa, et al. "Tumors With TSC Mutations Are Sensitive to CDK7 Inhibition Through NRF2 and Glutathione Depletion." J Exp Med 2019.
Styl cytowania MLAZarei, Mahsa, et al. "Tumors With TSC Mutations Are Sensitive to CDK7 Inhibition Through NRF2 and Glutathione Depletion." J Exp Med 2019.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..